Reducing Risk In Continuous Downstream Bioprocessing: 3 Innovations Process Engineers Can Use Today

Continuous downstream bioprocessing promises real gains in efficiency, flexibility, and cost, but the transition from batch operations introduces risks that can stall even the most promising programs. Extended run durations of 30 to 90 days, evolving regulatory frameworks, and the challenge of maintaining sterile, stable systems create a complex risk landscape that process engineers must navigate with precision.

Luckily, targeted innovations are already available to address these challenges head-on, from inline Raman spectroscopy enabling real-time process intelligence, to concentrated buffer stock strategies that simplify logistics and strengthen regulatory consistency, to single-use systems that reduce contamination risk and accelerate campaign changeover. This article outlines three innovations bioprocessing professionals can implement now, and explores how cross-functional collaboration and Quality by Design principles tie them together into a coherent risk reduction strategy.